# The Artificial Paracrine System: Robust Control of Extracellular-Vesicle Signaling Under Biological Uncertainty

**Author:** Devanik Debnath (Devanik21)  
**Affiliation:** Department of Electronics and Communication Engineering, National Institute of Technology Agartala, India  
**Research status:** Conceptual control-theoretic framework; no biological experiment is reported.  
**Release date:** 2026-10-10

## Abstract

This preprint formalizes an Artificial Paracrine System (APS): a hypothetical sensing–estimation–control–actuation architecture intended to regulate selected extracellular-vesicle (EV) signaling pathways. The proposal combines robust control, information-theoretic measurement limits, and a constrained manufacturing interface. It does not assume that aging is merely a communication failure, that EVs carry a universal youth signal, or that generative molecular design can safely synthesize arbitrary payloads in real time. Instead, it asks when a narrowly defined signaling objective could be stabilized under uncertain dynamics, delayed measurements, actuator limits, and biological safety constraints.

## Mathematical formulation

For a local linearized tissue model,

$$
\dot{x}(t)=Ax(t)+Bu(t)+Ew(t), \qquad y(t)=Cx(t)+v(t),
$$

where the state $x$ represents a specified tissue-level signaling and response state, $u$ is a bounded intervention, $w$ is an unmodeled disturbance, and $v$ is measurement noise. These variables are abstract and are not a clinical state vector.

A robust-control design objective may be expressed as

$$
\|T_{w\to z}\|_\infty < \gamma,
$$

for a defined closed-loop performance output $z$, admissible uncertainty set, and disturbance class. This is a design target, not a result established for living tissue here.

For a binary symmetric channel with error probability $p$, the capacity is

$$
C=1-H_2(p),\qquad H_2(p)=-p\log_2p-(1-p)\log_2(1-p),
$$

in bits per channel use. This is an illustrative communication model; biological signaling is not generally a binary symmetric channel.

## Main contribution and epistemic status

- **P1:** The linear-system definitions, controllability matrix, and binary-channel capacity formula follow from their assumptions.
- **P2:** Stabilization is conditional on model validity, controllability, actuator constraints, and controller-synthesis assumptions.
- **P3:** No universality or aging scaling exponent is claimed.
- **P4:** The correspondence between molecular signaling and communication/control systems is structural, not proof of a shared mechanism.
- **P5:** The “digital kernel” and “software failure” metaphors are explanatory analogies only and are not evidence.

The potential contribution is a falsifiable integration framework and validation checklist. Novelty is not claimed as established priority; EV therapeutics, aging-related EV signaling, microfluidics, and robust control each have prior literature.

## Reproducibility

Requirements: Python 3.10+ and NumPy 1.24+. Run from this directory:

```bash
python verify_model.py
```

Random seed: `20261010`. The script tests nominal closed-loop eigenvalues, controllability rank, 5,000 deterministic-seed bounded matrix perturbations, and binary-channel capacity limits. Passing the finite uncertainty sweep is not a formal $H_\infty$ proof. It does not simulate molecular synthesis, biodistribution, immune response, cancer risk, tissue rejuvenation, or a human organism.

## Falsification and evaluation plan

A future research program would first need a defined target tissue, measurable state variables, validated sensors, a bounded actuator, and a clinically meaningful endpoint. In vitro experiments would compare open-loop, feedback, sham, and conventional-payload controls; assess EV identity, cargo, potency, off-target effects, and batch variation; and test stability under predeclared perturbations. The proposal would be weakened or rejected if the measured state is not observable, if the target is not controllable within safe bounds, if disturbances exceed the assumed set, or if the apparent benefit is explained by toxicity, selection bias, or nonspecific stress responses. No human implantation or unsupervised intervention is proposed.

## Files in this release

- `paper.tex` — LaTeX manuscript and formal proposition.
- `paper.pdf` — compiled preprint.
- `verify_model.py` — deterministic synthetic numerical checks.
- `medium_story.md` — technical essay draft; not published externally.
- `x_thread.md` — 14-post X thread draft; not posted.
- `paper.bib` — BibTeX records for the cited literature.
- `CITATION.cff`, `.zenodo.json`, and `schema_article.jsonld` — citation and discovery metadata; no DOI or indexing is claimed.
- `deploy.py` — local validation and safe Git deployment helper.

## Author and public profiles

- GitHub: https://github.com/Devanik21
- Research archive: https://github.com/Devanik21/The-Invention-Archive
- ORCID: https://orcid.org/0009-0001-8310-6921
- Medium: https://medium.com/@devanik2005
- X: https://x.com/devanik2005
- LinkedIn profile (profile link only; no post created): https://www.linkedin.com/in/devanik
- Kaggle: https://www.kaggle.com/devanikdebnath and https://www.kaggle.com/devanik

No author-specific Google Scholar, OpenAIRE, or Zenodo record is asserted here. No DOI has been minted. External publication is not performed by this release workflow.

## References

1. Ma et al., “Engineering therapeutical extracellular vesicles for clinical translation,” *Trends in Biotechnology* (2025). https://doi.org/10.1016/j.tibtech.2024.08.007
2. Van Delen et al., “A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy,” *Journal of Extracellular Vesicles* (2024). https://doi.org/10.1002/jev2.12458
3. Yin et al., “Roles of extracellular vesicles in the aging microenvironment and age-related diseases,” *Journal of Extracellular Vesicles* (2021). https://doi.org/10.1002/jev2.12154
4. Takakura et al., “Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles,” *Pharmaceutical Research* (2024). https://doi.org/10.1007/s11095-024-03757-4
5. Zames, “Feedback and optimal sensitivity,” *IEEE Transactions on Automatic Control* (1981). https://doi.org/10.1109/TAC.1981.1102603

The literature supports EV communication and identifies translational challenges; it does not validate this proposed closed-loop system.
